MRI联合血清GPC3水平鉴别肝脏结节性增生病灶临床应用价值研究*

doi:10.3969/j.issn.1672-5069.2022.01.022

摘要/Abstract

摘要： 目的探究磁共振成像(MRI)联合血清磷脂酰肌醇蛋白聚糖3(GPC3)水平在鉴别诊断肝脏结节性增生(NRH)病灶方面的临床价值。方法 2016年3月～2019年8月我院诊治的NRH患者79例,经手术组织病理学检查结果为局灶性结节性增生(FNH)25例,肝细胞腺瘤(LCA)18例,异型增生结节(DN)20例和肝细胞癌(HCC)16例。采用ELISA法检测血清GPC3水平,使用西门子Avanto 3.0 T超导MRI检查设备和ADW 4.6后处理工作站行MRI检查。应用受试者工作特征曲线(ROC)分析MRI联合血清GPC3对四种病变的鉴别诊断价值。结果 HCC组血清GPC3水平为(2.2±0.4)ng/ml,显著高于FNH组或LCA组【分别为(1.0±0.2)ng/ml和(1.2±0.2)ng/ml,P<0.05】,而与DN组血清GPC3水平【(1.8±0.3)ng/ml,P>0.05】比,无显著性差异;MRI鉴别HCC、DN、FNH与LCA的准确率分别为88.0%(22/25)、88.9%(16/18)、70.0%(14/20)和75.0%(12/16),无显著性差异(P>0.05);MRI联合血清GPC3水平鉴别诊断HCC的AUC为0.760,显著大于诊断其他三种病变(分别为0.610、0.611和0.614,P<0.05)。结论 MRI联合血清GPC3水平检测诊断HCC具有较大的临床应用价值,值得进一步验证。

关键词: 肝脏结节性增生病灶, 磁共振成像, 脂酰肌醇蛋白聚糖3, 诊断

Abstract: Objective The aim of this study was to investigate the diagnostic value of magnetic resonance imaging (MRI)and serum glypican 3 (GPC3) levels in patients with nodular regenerative hyperplasia (NRH). Methods A total of 79 patients with NRH were admitted to our hospital between March 2016 and August 2019. Serum GPC3 levels were detected by ELISA, and all patients underwent MRI scan. After finishing the check-up, all patients received hepatectomy. The differential value of MRI and serum GPC3 levels for the four types of hepatic lesions was analyzed by receiver operating characteristic (ROC) curves. Results The post-operational histopathological examination showed focal nodular hyperplasia (FNH) in 25 cases, liver cell adenoma (LCA) in 18 cases, dysplasia nodule(DN) in 20 cases and hepatocellular carcinoma (HCC) in 16 cases; serum GPC3 level in patients with HCC was (2.2±0.4) ng/ml, significantly higher than (1.0±0.2) ng/ml in patients with FNH, or (1.2±0.2) ng/ml in patients with LCA (P<0.05), while serum GPC3 level in patients with DN was (1.8±0.3) ng/ml, not significantly different compared to that in patients with HCC (P>0.05); the accuracy by MRI in diagnosing HCC, DN, FNH and LCA were 88.0%(22/25), 88.9%(16/18), 70.0%(14/20) and 75.0%(12/16), not significantly different (P>0.05); the AUC of MRI and serum GPC3 level combination in diagnosing HCC was 0.760, significantly higher than in other three hepatic lesions (0.610, 0.611 and 0.614, respectively, P<0.05). Conclusion MRI and serum GPC3 level combination in distinguishing hepatic NRH is promising and efficacious, which warrants further clinical investigations.

Key words: Nodular regenerative hyperplasia, MRI, Glypican 3, Diagnosis

谭玉英, 张鑫, 张娟子, 张山西. MRI联合血清GPC3水平鉴别肝脏结节性增生病灶临床应用价值研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 88-91.

Tan Yuying, Zhang Xin, Zhang Juanzi, et al. Diagnostic value of MRI and serum GPC3 levels in patients with nodular regenerative hyperplasia[J]. Journal of Practical Hepatology, 2022, 25(1): 88-91.

参考文献

[1] Barge S, Grando V, Nault JC, et al. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies. Liver Int, 2016, 36(7):1059-1066.
[2] Gu K, Jeon TY, Yoo SY, et al. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors. Eur Radiol, 2021, 31(1):283-291.
[3] 汤笑禹, 王砚春, 卢仁泉, 等. 血清GPC3水平在原发性肝细胞癌患者辅助诊断中的应用价值. 中华预防医学杂志, 2020, 54(9):998-1002.
[4] Seinen ML, van Asseldonk DP, de Boer NK, et al. Nodular regenerative hyperplasia of the liver in patients with IBD treated with allopurinol-thiopurine combination therapy. Inflamm Bowel Dis, 2017, 23(3):448-452.
[5] Cannella R, Rangaswamy B, Minervini MI, et al. Value oftexture analysis on gadoxetic acid-enhanced MRI for differentiating hepatocellular adenoma from focal nodular hyperplasia. AJR, 2019, 212(3):538-546.
[6] 高德军, 陈耀康, 罗鹰, 等. 3.0 T MR-LAVA序列多期动态增强扫描对肝硬化结节病变定性诊断的临床价值研究.实用肝脏病杂志, 2019, 22(3):96-99.
[7] Choi SH, Kim KW, Kwon HJ, et al. Clinical usefulness of gadoxetic acid-enhanced MRI for evaluating biliary anatomy in living donor liver transplantation. Eur Radiol, 2019, 29(12):6508-6518.
[8] Badea R, Meszaros M, Al Hajjar N, et al. Benign nodular hyperplasia of the liver-pedunculated form: diagnostic contributions of ultrasonography and consideration of exophytic liver tumors. J Med Ultrason, 2015, 42(1):97-102
[9] Sonomura T, Anami S, Takeuchi T, et al. Reactive lymphoid hyperplasia of the liver:Perinodular enhancement on contrast-enhanced computed tomography and magnetic resonance imaging. World J Gastroenterol, 2015, 21(21):6759-6763.
[10] 方勇超, 王强, 唐权, 等. MSCT与MRI动态增强扫描对高血供肝内胆管癌与肝细胞癌的诊断价值分析. 实用肝脏病杂志, 2020, 23(6):131-134.
[11] Nowicki TK, Markiet K, Izycka-Swieszewska E, et al. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. BMC Gastroenterol, 2018, 18(1):10-14.
[12] Guo Y, Li W, Xie Z, et al. Diagnosticvalue of Gd-EOB-DTPA-MRI for hepatocellular adenoma: A Meta-analysis. J Cancer, 2017, 8(7):1301-1310.
[13] 李烨, 刘爱连, 郭妍, 等. 动态对比增强磁共振成像Ktrans与HPI纹理分析对肝细胞癌及结直肠癌肝转移瘤的鉴别价值. 中华临床医师杂志:电子版, 2018, 12(9):512-517.
[14] Suh CH, Kim KW, Park SH, et al. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Eur Radiol, 2018, 28(1):214-225.
[15] 汪禾青, 杨春, 盛若凡, 等. 肝脏局灶性结节性增生与炎症型肝细胞腺瘤的MRI表现和鉴别诊断. 中华肝胆外科杂志, 2018, 24(6):361-366.
[16] Shiozawa K, Watanabe M, Ikehara T, et al. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer. J Clin Ultrasound, 2017, 45(3):138-144.
[17] 吴燕京. 19例肝脏局灶性结节性增生的临床和影像学特点. 中华消化杂志, 2015, 35(2):95-98.
[18] Wang Q, Guo Y, Zhang J, et al. Contribution of IVIM toconventional dynamic contrast enhanced and diffusion-weighted MRI in differentiating benign from malignant breast masses. Breast Care (Basel), 2016, 11(4):254-258.
[19] Kim B, Byun JH, Lee JH, et al. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size. Clin Radiol, 2018, 73(3):244-253.
[20] Gawande R, Jalaeian H, Niendorf E, et al. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction. Eur J Radiol, 2019, 118(9):88-95.

MRI联合血清GPC3水平鉴别肝脏结节性增生病灶临床应用价值研究^*

Diagnostic value of MRI and serum GPC3 levels in patients with nodular regenerative hyperplasia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨艳, 刘婷, 戴琳, 努丽曼姑·麦麦提, 刘环. 声触诊弹性成像检测肝脾硬度诊断慢性乙型肝炎患者肝纤维化效能分析^*[J]. 实用肝脏病杂志, 2022, 25(2): 183-186.
[2]	黄平, 曾霞, 张亚萍, 毛加丽. 肝静脉波形分型联合肝脏超声半定量评分对慢性乙型肝炎患者肝纤维化程度评估价值研究^*[J]. 实用肝脏病杂志, 2022, 25(2): 187-190.
[3]	曲颖, 蔡晓波, 张启迪, 陆伦根. 体检人群血清M2型抗线粒体抗体流行率调查^*[J]. 实用肝脏病杂志, 2022, 25(2): 203-206.
[4]	郑小勤, 徐辉, 李丽, 靳华, 汪晓军, 勾春燕. 家族聚集性原发性胆汁性肝硬化患者临床特征分析[J]. 实用肝脏病杂志, 2022, 25(2): 207-210.
[5]	刘松涛, 刘梅, 渠亚超, 李瑞利, 邵晨, 闾军. 4例原发性肝脏神经内分泌肿瘤临床分析及文献复习[J]. 实用肝脏病杂志, 2022, 25(2): 251-254.
[6]	何福亮, 马琳, 李悦榕, 王宇, 王民, 冯丽娟, 张冠华, 欧晓娟, 刘福全, 贾继东. 非肝硬化性门脉高压的临床诊断[J]. 实用肝脏病杂志, 2022, 25(1): 1-4.
[7]	陈靖, 朱月永. 无创诊断肝硬化门静脉高压症:血清标志物还是影像学检查？[J]. 实用肝脏病杂志, 2022, 25(1): 9-12.
[8]	叶超, 李文渊, 李磊, 陈思, 李未, 张开光. 一组不明原因的肝损害患者肝组织病理学诊断研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 38-41.
[9]	李艳乐, 刘笑宇, 姚建宁, 王春峰, 张连峰, 张学秀. 乙型肝炎肝硬化并发肝性脑病患者血氨水平与认知障碍关系研究^*[J]. 实用肝脏病杂志, 2022, 25(1): 74-78.
[10]	李欢, 李扬, 杜娟, 梅放, 王玉湘, 郭丽梅. 肝细胞癌组织Glypican3和Sonic Hedgehog蛋白表达及其功能分析^*[J]. 实用肝脏病杂志, 2022, 25(1): 83-87.
[11]	肖倩, 周展, 胡小丽. 肝细胞癌患者肝内病灶超声造影参数变化^*[J]. 实用肝脏病杂志, 2022, 25(1): 92-95.
[12]	陈俊光, 邓晓妃, 林树俊, 雷震. 急性化脓性胆囊炎患者超声影像学特点及其诊断价值^*[J]. 实用肝脏病杂志, 2022, 25(1): 116-119.
[13]	杨帆, 王健, 文智. CT检查对诊断胆囊腺肌症的效能分析^*[J]. 实用肝脏病杂志, 2022, 25(1): 140-143.
[14]	汤磊, 邹桂舟. 外科疾病导致的胆源性肝损伤诊治现状[J]. 实用肝脏病杂志, 2021, 24(6): 769-771.
[15]	邢莉, 杜倩影, 姜艳丽, 韩冬. 分段注射对比剂CT增强扫描提高乙型肝炎肝硬化患者肝静脉显影效果研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 871-874.